Enantia offers chemical support to drug discovery programs covering the preparation of focused libraries, the synthesis of building blocks and scaffolds, the preparation of reference standards and metabolites and the GLP production for preclinical studies.
The company’s medicinal chemistry platform is formed by a balanced team of highly skilled organic chemists, combined with experienced medicinal chemists coming from the pharmaceutical industry with a solid background in the design of small molecules as ligands for a broad range of therapeutic targets belonging to different classes such as GPCRs, enzymes (kinase and non-kinase) and nuclear receptors.